Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence
Research on New Diagnosis and Treatment Technologies for Major Traditional Chinese Medicine Advantage Diseases - Multi-Omics and Artificial Intelligence-Driven Innovative TCM Diagnosis and Treatment Technologies for Diabetic Nephropathy
Sponsor: Jiazhen Yin
Listed as NCT07459946, this NA trial focuses on Chronic Renal Failure/ Kidney Disease and Diabetic Nephropathy Type 2 and remains actively recruiting participants. Sponsored by Jiazhen Yin, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recordedEligibility Summary
No eligibility information available.
Contact Information
- Jiazhen Yin
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.